Association of Long-Acting Injectable Antipsychotics and Oral Antipsychotics With Disease Relapse, Health Care Use, and Adverse Events Among People With Schizophrenia-Reference-Cited by-同舟云学术

Association of Long-Acting Injectable Antipsychotics and Oral Antipsychotics With Disease Relapse, Health Care Use, and Adverse Events Among People With Schizophrenia

Published:2022-07-28 Issue:7 Volume:5 Page:e2224163
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Wei Yue¹,Yan Vincent K. C.¹,Kang Wei¹,Wong Ian C. K.¹²³,Castle David J.⁴⁵,Gao Le¹,Chui Celine S. L.²⁶⁷,Man Kenneth K. C.¹²³,Hayes Joseph F.⁸,Chang Wing Chung⁹¹⁰,Chan Esther W.¹²¹¹

Affiliation:

1. Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong Special Administration Region (SAR), China

2. Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong SAR, China

3. Research Department of Practice and Policy, University College London School of Pharmacy, London, United Kingdom

4. Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada

5. Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada

6. School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China

7. School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China

8. Division of Psychiatry, University College London, London, United Kingdom

9. Department of Psychiatry, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China

10. State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong SAR, China

11. The University of Hong Kong Shenzhen Institute of Research and Innovation, Shenzhen, Guangdong, China

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2794734/wei_2022_oi_220682_1658348592.89483.pdf

Reference38 articles.

1. Schizophrenia—an overview.;McCutcheon;JAMA Psychiatry,2020

2. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.;Lieberman;N Engl J Med,2005

3. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors.;Valenstein;Schizophr Bull,2004

4. Pharmacokinetic characteristics of long-acting injectable antipsychotics for schizophrenia: an overview.;Correll;CNS Drugs,2021

5. Patterns of long acting injectable antipsychotic use and associated clinical factors in schizophrenia among 15 Asian countries and region.;Tang;Asia Pac Psychiatry,2020

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis;Molecular Psychiatry;2024-08-22

2. Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis;Nature Communications;2024-07-05

3. Long-Acting Injectable Antipsychotics in the Geriatric Population: A longitudinal Study;The American Journal of Geriatric Psychiatry;2024-07

4. Assessing the impact of long‐acting injectable compared to oral antipsychotic medications on readmission to a state psychiatric hospital;Journal of Psychiatric and Mental Health Nursing;2024-06-22

5. Finding the Right Setting for the Right Treatment During the Acute Treatment of Individuals with Schizophrenia: A Narrative Review and Clinical Practice Guideline;Neuropsychiatric Disease and Treatment;2024-06